FDA had inadequate policies to heed warnings about infant formula, probe finds
(NEW YORK) -- The Food and Drug Administration failed to heed warning signs that there were mounting concerns with one of the nation's largest infant formula makers, as a series of babies' severe illnesses and whistleblower complaints began to accumulate ahead of a critical...
